Volume 16, Number 5—May 2010
Research
Latent Tuberculosis among Persons at Risk for Infection with HIV, Tijuana, Mexico
Table 1
Characteristic | Total (n = 503) | IGRA– (n = 217) | IGRA+ (n = 286) | Odds ratio (95% CI) |
---|---|---|---|---|
Risk factor†‡ | ||||
Injected drugs | 232 (46.1) | 86 (39.6) | 146 (51.1) | 1.59 (1.11–2.27) |
Used drugs but never injected | 207 (41.2) | 94 (43.3) | 113 (39.5) | 0.86 (0.60–1.22) |
Sex work | 115 (22.9) | 59 (27.2) | 56 (19.6) | 0.65 (0.43-0.99) |
Homeless/unstably housed | 280 (55.7) | 135 (62.2) | 145 (50.7) | 0.63 (0.44–0.90) |
Median age, y (IQR) |
36.0 (29–42) |
34.0 (28–40) |
38.0 (31–43) |
1.04 (1.02–1.06) |
Sex | ||||
M | 297 (59.0) | 112 (51.6) | 185 (64.7) | 1.00 |
F | 193 (38.4) | 99 (45.6) | 94 (32.9) | 0.58 (0.40–0.83) |
Transgender |
13 (2.6) |
6 (2.8) |
7 (2.5) |
0.71 (0.23–2.16) |
Years lived in Tijuana, median (IQR) | 6.04 (1–13.3) | 3.51 (0.3–10.0) | 9.0 (3.0–16.4) | 1.03 (1.012–1.04) |
Most frequent type of sleeping arrangement‡ | ||||
Stable | 223 (44.3) | 82 (37.8) | 141 (49.3) | 1.00 |
Unstable housing | 209 (41.6) | 105 (48.4) | 104 (36.4) | 0.58 (0.39–0.85) |
Homeless |
71 (14.1) |
30 (13.8) |
41 (14.3) |
0.80 (0.46–1.37) |
Ever incarcerated | 338 (67.2) | 128 (59.0) | 210 (73.4) | 1.92 (1.32–2.80) |
Incarceration status | ||||
Never jailed | 165 (32.8) | 89 (41.0) | 76 (26.6) | 1.00 |
Jailed in USA only | 129 (25.6) | 58 (26.7) | 71(24.8) | 1.43 (0.90–2.28) |
Jailed in Mexico or Mexico and USA |
209 (41.5) |
70 (32.3) |
139 (48.6) |
2.33 (1.53–3.54) |
Noninjection drug used most often‡ | ||||
None | 157 (31.2) | 67 (30.9) | 90 (31.5) | 1.00 |
Methamphetamines | 218 (43.3) | 101 (46.5) | 117 (40.9) | 0.86 (0.57–1.30) |
Heroin | 52 (10.3) | 14 (6.5) | 38 (13.3) | 2.02 (1.01–4.03) |
Any other drug |
76 (15.1) |
35 (16.1) |
41 (14.3) |
0.87 (0.50–1.51) |
Ever injected illegal drugs | 248 (49.3) | 92 (42.4) | 156 (54.6) | 1.63 (1.14–2.33) |
Mean (SD) years injected drugs among IDUs |
13.5 (13.0) |
13.0 (13.5) |
14.0 (14.0) |
1.02 (0.99–1.05) |
Ever known anyone with TB | 210 (41.8) | 78 (35.9) | 132 (46.2) | 1.53 (1.06–2.19) |
*Values are no. (%) unless otherwise indicated. IGRA, interferon-γ release assay; CI, confidence interval; IQR, interquartile range; IDUs, injection drug users; TB, tuberculosis.
†Risk groups are not mutually exclusive; reference group includes all participants without the characteristic.
‡Refers to the past 6 mo.
Page created: December 23, 2010
Page updated: December 23, 2010
Page reviewed: December 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.